Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceJulie Strizki, Nicholas Murgolo, John A. Howe et al.|Antimicrobial Agents and Chemotherapy|2023Cited by 33